Ins(123456)P6
|
|
83-86-3
|
Ins(135)P3*6Na
|
|
|
Ins(1)P*2K
|
|
313263-16-0
|
Ins(23456)P5*10Na
|
|
109526-12-7
|
Ins(13456)P5*10Na
|
|
20298-95-7
|
myo-Inositol – trispyrophosphate
|
|
623552-11-4
|
SH-5
|
|
701976-54-7
|
Ins(145)P3*6K
|
|
103476-24-0
|
Ins(145)P3*3Li
|
|
129828-69-9
|
Ins(12456)P5*10Na
|
|
183075-26-5
|
2-Oleoyl-glycerol
|
|
3443-84-3
|
Ins(145)P3*6Na
|
|
108340-81-4
|
Ins(1345)P4*8Na
|
|
135269-51-1
|
Gestodene Impurity E
|
|
|
Bt3-Ins(136)P3 / AM
|
|
|
Prasugrel metabolite M6-d3 (stabilzed)
|
|
1234692-58-0
|
Prasugrel metabolite M6
|
|
947530-51-0
|
Clopidogrel Impurity 3
|
|
141109-18-4
|
Prasugrel active metabolite M3-d3 (stabilzed)
|
|
1619986-66-1
|
Fidaxomicin Metabolite OP-1118
|
|
1030825-28-5
|
1,4-Di-butyryl-23:56-diisopropylidene-myo-Inositol
|
|
1620222-02-7
|
12:56- diisopropylidene-myo-Inositol
|
|
211294-79-0
|
3,6-Di-butyryl-12:45-diisopropylidene-myo-Inositol
|
|
1307298-34-5
|
3,4,5,6-Tetra-O-Benzyl-Ins
|
|
24558-77-8
|
23:45- diisopropylidene-myo-Inositol
|
|
211294-75-6
|
2,3:4,5-Di-O-Iso-1,6-Di-O-Benzyl-Ins
|
|
131233-62-0
|
PtdIns(3)P
|
|
165689-81-6
|
PtdIns(1)P
|
|
62742-56-7
|
1,4,5,6-Tetra-O-Benzyl-Ins
|
|
26276-99-3
|
Podophyllotoxin Derivate
|
|
117507-84-3
|
Bt2-Ins(1356)P4 / AM
|
|
164199-43-3
|
Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(2-cyanoethyl) ester
|
|
102690-88-0
|
Phosphoramidous acid. N.N-bis(1-methylethyl)-. 2-cyanoethyl [1-(2-nitrophenyl)ethyl] ester)
|
|
461425-49-0
|
Didechloro Vancomycin
|
|
98510-30-6
|
Vancomycin Impurity A
|
|
91700-98-0
|
3'-PAP
|
|
1053-73-2
|
Vancomycin hexapeptide
|
|
115236-65-2
|
Vancomycin Impurity D
|
|
101485-50-1
|
Fidaxomicin - d7
|
|
873857-62-6
|
Vancomycin Impurity B
|
|
55598-85-1
|
Vancomycin Impurity C
|
|
82198-76-3
|
Podophyllotoxin Derivate
|
|
6559-91-7
|
Phosphoramidous acid, N,N-bis(1-methylethyl)-, bis(phenylmethyl) ester
|
|
108549-23-1
|
Naphthalene 13C6
|
|
1192501-11-3
|
2-Cyanoethyl N,N-diisopropylchlorophosphoramidite
|
|
89992-70-1
|
35-PAPS-Li
|
|
102029-54-9
|
Anthracene 13C6
|
|
189811-60-7
|
D-myo-Inositol-2,3-O-cyclohexylidene
|
|
57029-87-5
|
Clopidogrel Impurity C
|
|
1346605-15-9
|
Bt3-Ins(346)P3 / PM
|
|
503158-16-5
|
Ins(1245)P4*8Na
|
|
170715-18-1
|
caged-Ins(145)P3 / PM
|
|
1009832-82-9
|
Bt3-Ins(135)P3 / PM
|
|
503158-15-4
|
Bt3-Ins(146)P3 / PM
|
|
503158-17-6
|
INO-4995
|
|
868171-91-9
|
Clopidogrel Impurity 4
|
|
144457-43-2
|
DEAC-dUTP
|
|
|
Phosphorodiamidous acid. N.N.N'.N'-tetrakis(1-methylethyl)-. phenylmethyl ester
|
|
108549-21-9
|
Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(9H-fluoren-9-ylmethyl) ester
|
|
197709-11-8
|
Dichloro N,N-Diisopropylphosphoramidite
|
|
921-26-6
|
Bt3-Ins(146)P3 / AM
|
|
431900-02-6
|
Bt2-Ins(3456)P4 / PM
|
|
1233512-98-5
|
35-PAPS-TEA
|
|
936827-87-1
|
25-PAPS-Li
|
|
62230-89-1
|
EdUTP
|
|
111289-87-3
|
EdUTP-TEA
|
|
1191275-46-3
|
3'-PAP-Na
|
|
75431-54-8
|
PtdIns(4)P
|
|
57606-15-2
|
Bt3-Ins(145)P3 / AM
|
|
164007-69-6
|
Bt3-Ins(135)P3 / AM
|
|
1258008-22-8
|
caged-Ins(145)P3 P4
|
|
119147-20-5
|
PtdIns(45)P2
|
|
120595-88-2
|
PtdIns(34)P2
|
|
165883-85-2
|
TMe-OHB-DAZA
|
|
2241024-76-8
|
CoA-Cy3
|
|
|
CoA-Cy5
|
|
|
Di-benzyl chloromethyl phosphate
|
|
258516-84-6
|
Di-tert-butyl chloromethyl phosphate
|
|
229625-50-7
|
caged-Ins(145)P3O6
|
|
887903-55-1
|
PtdIns(5)P
|
|
291527-75-8
|
2'-PAP
|
|
3805-37-6
|
Naphthalene 13C10
|
|
219526-41-7
|
Bt2-Ins(1345)P4 / PM
|
|
503158-20-1
|
Prasugrel active metabolite M3 HCl (stabilized)
|
|
1287383-06-5
|
Bt3-Ins(356)P3 / PM
|
|
|
Ins(345)P3*3K
|
|
348128-32-5
|
Ins(134)P3*6K
|
|
140385-74-6
|
SH-6
|
|
701976-55-8
|
Bt3-Ins(346)P3 / AM
|
|
431900-03-7
|
|
SiChem
|
|
Phenanthrene 13C6
|
|
1189955-53-0
|
Bt3-Ins(134)P3 / AM
|
|
205247-51-4
|
Ins(345)P3*3Na
|
|
112791-62-5
|
2'-PAP-Na
|
|
108347-94-0
|
Bt3-Ins(356)P3 / AM
|
|
164199-42-2
|
PtdIns(345)P3
|
|
165689-82-7
|
D-myo-Inositol-1,2-O-cyclohexylidene
|
|
55123-25-6
|
Methyl 4-(2-hydroxyethyl)benzoate-13C6,2D (Ring-13C6,Ethyl-1,2-D2)
|
|
|
Ins(12345)P5*10Na
|
|
183075-27-6
|
Ins(136)P3*6Na
|
|
93133-75-6
|